Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Medical device company MedaSorb Technologies and its wholly-owned subsidiary, CytoSorbents, have announced that Phillip Chan has officially joined the company as interim CEO, replacing Al Kraus who stepped down at the end of December 2008.
Subscribe to our email newsletter
The company has also announced that Al Kraus has been elected to chairman of the board. William Miller has stepped down as chairman after two years of service.
The company also announced that James Winchester has stepped down from his position as chief medical officer. Due to increased restrictions on third party consulting agreements with his primary employer, Dr Winchester elected to relinquish his position at MedaSorb.
Concurrent with Dr Winchester’s departure, MedaSorb announced that Robert Bartlett will join the company as its new chief medical officer. Dr Bartlett is professor emeritus of surgery at the University of Michigan Health System.
Dr Chan said: “We are truly fortunate to have Dr Bartlett join the company as chief medical officer. Dr Bartlett provides the exact expertise the company needs at this juncture and we are excited to work with him more closely.”